missing translation for 'onlineSavingsMsg'
Learn More

PI3 Kinase p110 Alpha Rabbit, anti-Human, Clone: 1B4, Proteintech

Rabbit Recombinant Monoclonal Antibody

£135.00 - £360.00

Specifications

Antigen PI3 Kinase p110 Alpha
Clone 1B4
Concentration 1000 μg/mL
Applications Western Blot, ELISA
Form Liquid
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18035385
View Documents
Proteintech
82796-4-RR-100UL
100 μL
£360.00
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18008315
View Documents
Proteintech
82796-4-RR-20UL
20 μL
£135.00
20µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

The PI3 Kinase p110 Alpha antibody from Proteintech is a rabbit recombinant antibody generated with recombinant protein of human PI3 Kinase p110 Alpha. This antibody recognizes human, mouse, rat antigen. The PI3 Kinase p110 Alpha antibody has been validated for the following applications: WB, ELISA analysis.

Specifications

Specifications

PI3 Kinase p110 Alpha
1000 μg/mL
Liquid
Human, Mouse, Rat
p110 alpha, PI3 kinase subunit alpha, PI3K, PI3K alpha, PIK3CA, PtdIns 3 kinase subunit alpha
Primary
1B4
Western Blot, ELISA
Rabbit
5290
IgG
Store at -20°C. Stable for one year after shipment.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.